Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-02-13, Stock:ABBV, The news for the past five days is as follows:
2020-02-06: NEWS1: Q4 Earnings Outlook For AbbVie.NEWS2: Form 8.3 - ABBVIE INC - Amendment.NEWS3: AbbVie Climbs Pre-Earnings on Analyst Nod, Coronavirus Drug Demand.NEWS4: Allergan (AGN) to Report Q4 Earnings: What's in the Cards?.NEWS5: Form 8.3 - ABBVIE INC - AMENDMENT.
2020-02-07: NEWS1: Stocks end lower as market retreats from records.NEWS2: AbbVie Stock Breaks Out As Humira Sales Top Bearish Expectations.NEWS3: US Stock Market Red on Friday.NEWS4: AbbVie's (ABBV) Q4 Earnings Beat, 2020 View Solid, Stock Up.NEWS5: Stock market retreats from records; January job growth soars above expectations.NEWS6: AbbVie Stock Flirts With A Breakout On Solid Fourth-Quarter Earnings.NEWS7: FORM 8.3 - ABBVIE PLC - AMENDMENT.NEWS8: Pharma Stock Roundup: BMY, GSK, SNY Q4 Results, MRK Earnings & Split.NEWS9: AbbVie Tops Q4 Profit Forecast, Sees Solid 2020 as New Drugs Boost Sales.NEWS10: AbbVie Earnings Top, Guidance Solid; Drug Giant Rises Toward Buy Point.NEWS11: AbbVie Jumps on Strong Earnings. That’s Not the Only Reason..NEWS12: AbbVie (ABBV) Q4 Earnings and Revenues Beat Estimates.NEWS13: AbbVie Reports Q4 Earnings Beat.NEWS14: AbbVie's stock rises on strong earnings.NEWS15: New drugs contribute to AbbVie's upbeat 2020 view; shares hit year-high.NEWS16: AbbVie leans on new treatments to forecast upbeat 2020 profit.NEWS17: AbbVie Reports Full-Year and Fourth-Quarter 2019 Financial Results.NEWS18: AbbVie Posts Solid Quarter With Remarkably Strong Growth From Next-Generation Immunology Drugs.NEWS19: Form 8.3 - ABBVIE INC.NEWS20: AbbVie Stock Rises 3%.NEWS21: AbbVie Earnings Beat, Revenue Inline In Q4.NEWS22: AbbVie boosts outlook despite competition from generic drugs.NEWS23: AbbVie boosts 2020 outlook despite competition from generic drugs.
2020-02-10: NEWS1: Allergan Rides Botox Sales To Top Forecasts As AbbVie Merger Looms.NEWS2: Allergan (AGN) Surpasses Q4 Earnings and Sales Estimates.NEWS3: Wall Street Opens Higher Monday.NEWS4: Allergan Tops Q4 Earnings Forecast, Sees $63 Billion AbbVie Deal Closing in Q1.NEWS5: Easy Investing Secrets to an Early Retirement - February 10, 2020.NEWS6: Allergan Earnings Top Ahead Of Takeover By AbbVie.NEWS7: AbbVie Is Nearing Takeover Of Allergan — Is It Time To Add AbbVie Stock?.NEWS8: Allergan's stock rises as adjusted profit, revenue beat expectations.NEWS9: Form 8.3 - ABBVIE INC.NEWS10: AbbVie Stock Rises 3%.
2020-02-11: NEWS1: Coronavirus update: 1,018 deaths, a new case in San Diego, 195 evacuees expected to leave quarantine.NEWS2: Top Stock Research Reports for AbbVie, Accenture, TOTAL & Others.NEWS3: AbbVie to Present at the SVB Leerink 9th Annual Global Healthcare Conference.NEWS4: Form 8.3 - ABBVIE INC.NEWS5: Form 8.3 - Abbvie Plc - Amendment.
2020-02-12: NEWS1: Edited Transcript of ABBV earnings conference call or presentation 7-Feb-20 2:00pm GMT.NEWS2: Buy AbbVie for its Growth Prospects, Yield and Low Valuation.NEWS3: Form 8.3 - Abbvie Plc - Amendment.NEWS4: The Zacks Analyst Blog Highlights: AbbVie, Accenture, TOTAL, Amazon.com and Intuit.NEWS5: FORM 8.3 - ABBVIE PLC.NEWS6: Form 8.3 - ABBVIE INC - Amendment.

Answer: Decrease